A detailed history of Avantax Planning Partners, Inc. transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Avantax Planning Partners, Inc. holds 279,541 shares of HCWB stock, worth $120,202. This represents 0.01% of its overall portfolio holdings.

Number of Shares
279,541
Previous 179,777 55.49%
Holding current value
$120,202
Previous $314,000 42.36%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.64 - $1.68 $63,848 - $167,603
99,764 Added 55.49%
279,541 $181,000
Q1 2024

May 02, 2024

BUY
$1.1 - $1.77 $259 - $417
236 Added 0.13%
179,777 $314,000
Q4 2023

Feb 09, 2024

BUY
$0.92 - $2.14 $165,177 - $384,217
179,541 New
179,541 $220,000

Others Institutions Holding HCWB

About HCW Biologics Inc.


  • Ticker HCWB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,833,100
  • Market Cap $15.4M
  • Description
  • HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...
More about HCWB
Track This Portfolio

Track Avantax Planning Partners, Inc. Portfolio

Follow Avantax Planning Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Planning Partners, Inc. with notifications on news.